Dopamine D2Rs coordinate cue-evoked changes in striatal acetylcholine levels.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
20 07 2022
Historique:
received: 03 12 2021
accepted: 19 07 2022
pubmed: 21 7 2022
medline: 11 8 2022
entrez: 20 7 2022
Statut: epublish

Résumé

In the striatum, acetylcholine (ACh) neuron activity is modulated co-incident with dopamine (DA) release in response to unpredicted rewards and reward-predicting cues and both neuromodulators are thought to regulate each other. While this co-regulation has been studied using stimulation studies, the existence of this mutual regulation in vivo during natural behavior is still largely unexplored. One long-standing controversy has been whether striatal DA is responsible for the induction of the cholinergic pause or whether DA D2 receptors (D2Rs) modulate a pause that is induced by other mechanisms. Here, we used genetically encoded sensors in combination with pharmacological and genetic inactivation of D2Rs from cholinergic interneurons (CINs) to simultaneously measure ACh and DA levels after CIN D2R inactivation in mice. We found that CIN D2Rs are not necessary for the initiation of cue-induced decrease in ACh levels. Rather, they prolong the duration of the decrease and inhibit ACh rebound levels. Notably, the change in cue-evoked ACh levels is not associated with altered cue-evoked DA release. Moreover, D2R inactivation strongly decreased the temporal correlation between DA and ACh signals not only at cue presentation but also during the intertrial interval pointing to a general mechanism by which D2Rs coordinate both signals. At the behavioral level D2R antagonism increased the latency to lever press, which was not observed in CIN-selective D2R knock out mice. Press latency correlated with the cue-evoked decrease in ACh levels and artificial inhibition of CINs revealed that longer inhibition shortens the latency to press compared to shorter inhibition. This supports a role of the ACh signal and it's regulation by D2Rs in the motivation to initiate actions.

Identifiants

pubmed: 35856493
doi: 10.7554/eLife.76111
pii: 76111
pmc: PMC9363114
doi:
pii:

Substances chimiques

Cholinergic Agents 0
Receptors, Dopamine D2 0
Acetylcholine N9YNS0M02X
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : F99 NS120642
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH093672
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH124858
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH126380
Pays : United States

Informations de copyright

© 2022, Martyniuk et al.

Déclaration de conflit d'intérêts

KM, AT, DL, MR, ML, CK No competing interests declared

Références

Eur J Neurosci. 2015 Jul;42(2):1764-74
pubmed: 25865337
J Neurosci. 2007 Jan 10;27(2):391-400
pubmed: 17215400
J Neurosci. 2010 Oct 27;30(43):14390-8
pubmed: 20980596
Cell Metab. 2011 Feb 2;13(2):195-204
pubmed: 21284986
Neuron. 2016 Apr 20;90(2):362-73
pubmed: 27100198
Science. 1994 Jul 15;265(5170):412-5
pubmed: 8023166
J Neurosci. 2014 Aug 27;34(35):11549-59
pubmed: 25164653
Front Psychol. 2017 Feb 22;8:244
pubmed: 28275359
Neuron. 2004 Jul 8;43(1):133-43
pubmed: 15233923
J Neurosci. 2011 Jan 26;31(4):1507-15
pubmed: 21273435
Trends Neurosci. 2006 Mar;29(3):125-31
pubmed: 16443285
Trends Neurosci. 2007 May;30(5):203-10
pubmed: 17400301
Nature. 2012 Dec 20;492(7429):452-6
pubmed: 23178810
Cell Rep. 2012 Jul 26;2(1):33-41
pubmed: 22840394
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4998-5001
pubmed: 6589643
Cell Rep. 2019 Feb 5;26(6):1389-1398.e3
pubmed: 30726725
Neuron. 2012 Jul 12;75(1):58-64
pubmed: 22794260
Cell Rep. 2015 Oct 27;13(4):657-666
pubmed: 26489458
Neurobiol Learn Mem. 2009 Jan;91(1):13-22
pubmed: 18845266
Eur J Neurosci. 2009 Aug;30(3):515-26
pubmed: 19656171
Biol Psychiatry. 2019 Sep 1;86(5):388-396
pubmed: 30955842
Front Behav Neurosci. 2014 May 23;8:188
pubmed: 24904339
Neuron. 2014 Feb 19;81(4):901-12
pubmed: 24559678
Neuron. 1997 Nov;19(5):1115-26
pubmed: 9390524
Nat Neurosci. 2011 Dec 11;15(1):123-30
pubmed: 22158514
Nat Methods. 2020 Nov;17(11):1139-1146
pubmed: 32989318
Neuron. 2005 Feb 17;45(4):575-85
pubmed: 15721243
J Neurosci. 2015 Jun 24;35(25):9424-31
pubmed: 26109665
Science. 2010 Dec 17;330(6011):1677-81
pubmed: 21164015
Exp Brain Res. 1997 Oct;116(3):456-66
pubmed: 9372294
J Neurophysiol. 1998 May;79(5):2568-80
pubmed: 9582229
Eur J Neurosci. 2018 May;47(10):1174-1183
pubmed: 29119611
Trends Neurosci. 2007 Jun;30(6):299-306
pubmed: 17420057
Mol Psychiatry. 2022 Mar;27(3):1502-1514
pubmed: 34789847
Basal Ganglia. 2016 Aug;6(3):123-148
pubmed: 27141430
Neuron. 2016 Jul 6;91(1):67-78
pubmed: 27387649
Cell Rep. 2018 Sep 11;24(11):2883-2893
pubmed: 30208314
Front Syst Neurosci. 2017 Oct 30;11:80
pubmed: 29163075
J Neurosci. 2014 Jun 18;34(25):8557-69
pubmed: 24948810
J Neurosci. 2014 Feb 19;34(8):3101-17
pubmed: 24553950
J Neurosci. 2008 Nov 5;28(45):11673-84
pubmed: 18987203
Science. 2021 Apr 23;372(6540):
pubmed: 33888613
J Neurophysiol. 2001 Feb;85(2):960-76
pubmed: 11160526
Neuron. 2013 Jul 10;79(1):153-66
pubmed: 23770257
Neuron. 2018 Jun 6;98(5):918-925.e3
pubmed: 29754751
Nat Neurosci. 2013 Jul;16(7):966-73
pubmed: 23708143
Nature. 2019 Jun;570(7759):65-70
pubmed: 31118513
J Clin Invest. 2020 Dec 1;130(12):6616-6630
pubmed: 33164988
J Neurosci. 1994 Jun;14(6):3969-84
pubmed: 8207500
Nat Neurosci. 2011 Jul 10;14(8):1033-8
pubmed: 21743470
Neurochem Int. 1997 Feb;30(2):191-7
pubmed: 9017666
Nat Commun. 2014 May 06;5:3778
pubmed: 24797209
Neuropsychopharmacology. 2021 Nov;46(12):2043-2047
pubmed: 33603136
Science. 2018 Jun 29;360(6396):
pubmed: 29853555
Science. 1997 Mar 14;275(5306):1593-9
pubmed: 9054347
Biol Psychiatry. 2019 Dec 1;86(11):836-847
pubmed: 31471038
Nat Neurosci. 2007 Aug;10(8):1020-8
pubmed: 17603481
J Neurophysiol. 1992 Sep;68(3):945-60
pubmed: 1432059
Neuron. 2010 Jul 29;67(2):294-307
pubmed: 20670836
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2726-31
pubmed: 26831103

Auteurs

Kelly M Martyniuk (KM)

Department of Neuroscience, Columbia University, New York, United States.
Department of Psychiatry, Columbia University, New York, United States.

Arturo Torres-Herraez (A)

Department of Psychiatry, Columbia University, New York, United States.
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.

Daniel C Lowes (DC)

Department of Psychiatry, Columbia University, New York, United States.
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.

Marcelo Rubinstein (M)

Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Consejo Nacional de Investigaciones Científicas y Técnicas, and Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.

Marie A Labouesse (MA)

Department of Psychiatry, Columbia University, New York, United States.
Department of Health Science and Technology, ETH Zurich, Schwerzenbach, Switzerland.
Zurich Neuroscience Center, Winterthurerstrasse, Zurich, Switzerland.

Christoph Kellendonk (C)

Department of Psychiatry, Columbia University, New York, United States.
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.
Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, United States.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH